These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 30066881)
1. EphA3 contributes to tumor growth and angiogenesis in human gastric cancer cells. Lv XY; Wang J; Huang F; Wang P; Zhou JG; Wei B; Li SH Oncol Rep; 2018 Oct; 40(4):2408-2416. PubMed ID: 30066881 [TBL] [Abstract][Full Text] [Related]
2. MACC-1 Promotes Endothelium-Dependent Angiogenesis in Gastric Cancer by Activating TWIST1/VEGF-A Signal Pathway. Wang L; Zhou R; Zhao Y; Dong S; Zhang J; Luo Y; Huang N; Shi M; Bin J; Liao Y; Liao W PLoS One; 2016; 11(6):e0157137. PubMed ID: 27280289 [TBL] [Abstract][Full Text] [Related]
3. EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway. Peng J; Wang Q; Liu H; Ye M; Wu X; Guo L Tumour Biol; 2016 Sep; 37(9):11959-11971. PubMed ID: 27101199 [TBL] [Abstract][Full Text] [Related]
4. C-X-C motif chemokine receptor 4 promotes tumor angiogenesis in gastric cancer via activation of JAK2/STAT3. Zhang Q; Xu F; Shi Y; Chen YW; Wang HP; Yu X; Li Y Cell Biol Int; 2017 Aug; 41(8):854-862. PubMed ID: 28544312 [TBL] [Abstract][Full Text] [Related]
5. Isoprenaline/β2-AR activates Plexin-A1/VEGFR2 signals via VEGF secretion in gastric cancer cells to promote tumor angiogenesis. Lu Y; Xu Q; Zuo Y; Liu L; Liu S; Chen L; Wang K; Lei Y; Zhao X; Li Y BMC Cancer; 2017 Dec; 17(1):875. PubMed ID: 29262812 [TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of EphA3 in gastric carcinoma: correlation with tumor angiogenesis and survival. Xi HQ; Wu XS; Wei B; Chen L J Gastroenterol; 2012 Jul; 47(7):785-94. PubMed ID: 22350700 [TBL] [Abstract][Full Text] [Related]
7. Mitochondrial ROS accumulation inhibiting JAK2/STAT3 pathway is a critical modulator of CYT997-induced autophagy and apoptosis in gastric cancer. Cao Y; Wang J; Tian H; Fu GH J Exp Clin Cancer Res; 2020 Jun; 39(1):119. PubMed ID: 32576206 [TBL] [Abstract][Full Text] [Related]
8. JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis. Chen JJ; Ren YL; Shu CJ; Zhang Y; Chen MJ; Xu J; Li J; Li AP; Chen DY; He JD; Shu YQ; Zhou JW J Exp Clin Cancer Res; 2020 Jun; 39(1):118. PubMed ID: 32576271 [TBL] [Abstract][Full Text] [Related]
9. SIRT6 inhibits growth of gastric cancer by inhibiting JAK2/STAT3 pathway. Zhou J; Wu A; Yu X; Zhu J; Dai H Oncol Rep; 2017 Aug; 38(2):1059-1066. PubMed ID: 28656307 [TBL] [Abstract][Full Text] [Related]
10. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo. Huang C; Jiang T; Zhu L; Liu J; Cao J; Huang KJ; Qiu ZJ Int J Oncol; 2011 Jun; 38(6):1637-44. PubMed ID: 21479358 [TBL] [Abstract][Full Text] [Related]
11. Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro. Zhu WQ; Wang J; Guo XF; Liu Z; Dong WG World J Gastroenterol; 2016 Apr; 22(16):4149-59. PubMed ID: 27122665 [TBL] [Abstract][Full Text] [Related]
12. (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis. Zhu BH; Zhan WH; Li ZR; Wang Z; He YL; Peng JS; Cai SR; Ma JP; Zhang CH World J Gastroenterol; 2007 Feb; 13(8):1162-9. PubMed ID: 17451194 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancer. Chen J; Wang J; Lin L; He L; Wu Y; Zhang L; Yi Z; Chen Y; Pang X; Liu M Mol Cancer Ther; 2012 Feb; 11(2):277-87. PubMed ID: 22203730 [TBL] [Abstract][Full Text] [Related]
14. [Epigallocatechin-3-gallate inhibits growth and angiogenesis of gastric cancer and its molecular mechanism]. Zhu BH; Zhan WH; He YL; Cai SR; Wang Z; Zhang CH Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):82-5. PubMed ID: 19145512 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-574-5p in gastric cancer cells promotes angiogenesis by targeting protein tyrosine phosphatase non-receptor type 3 (PTPN3). Zhang S; Zhang R; Xu R; Shang J; He H; Yang Q Gene; 2020 Apr; 733():144383. PubMed ID: 31972307 [TBL] [Abstract][Full Text] [Related]
16. CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer. Wei ZW; Xia GK; Wu Y; Chen W; Xiang Z; Schwarz RE; Brekken RA; Awasthi N; He YL; Zhang CH Cancer Lett; 2015 Apr; 359(2):335-43. PubMed ID: 25641338 [TBL] [Abstract][Full Text] [Related]
18. NFIB promotes cell growth, aggressiveness, metastasis and EMT of gastric cancer through the Akt/Stat3 signaling pathway. Wu C; Zhu X; Liu W; Ruan T; Wan W; Tao K Oncol Rep; 2018 Sep; 40(3):1565-1573. PubMed ID: 30015981 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of LINC00691 promotes the proliferation and invasion of gastric cancer cells via the Janus kinase/signal transducer and activator of transcription signalling pathway. Liang W; Xia B; He C; Zhai G; Li M; Zhou J Int J Biochem Cell Biol; 2020 Jun; 123():105751. PubMed ID: 32330554 [TBL] [Abstract][Full Text] [Related]
20. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer. Gong W; Wang L; Yao JC; Ajani JA; Wei D; Aldape KD; Xie K; Sawaya R; Huang S Clin Cancer Res; 2005 Feb; 11(4):1386-93. PubMed ID: 15746037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]